Abstract
With an interest in development of novel therapies for the management of pre-eclampsia and prolongation of gestation, we set out to determine which biomarkers of endothelial dysfunction are most strongly associated with disease activity and severity in patients with pre-eclampsia. The aim of this particular study was to assess the activity of biomarkers at delivery and in the postpartum period and to compare their activity in patients with pre-eclampsia with and without severe features.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
